Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Missouri
Pag-aaral pangklinika para sa Chronic Inflammatory Demyelinating Polyradiculoneuropathy sa Missouri
5 pag-aaral para sa Chronic Inflammatory Demyelinating Polyradiculoneuropathy ang naghahanap ng mga kalahok sa mga site sa Missouri.
Mga Lungsod sa Missouri
Opisyal na teksto ng pag-aaral (English)
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Kansas City Veterans Affairs Medical Center, Kansas City
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Washington University School of Medicine - Siteman Cancer Center- Site Number : 8400037, St Louis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06290141A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- The Curators of the University of Missouri on behalf of University of Missouri Health Care, Columbia
- The Washington University, St Louis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT06798012Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
- NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07478172A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- The Washington University, St Louis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06747351Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.